February 05, 2024 – Lyon, France
TheraPPI Bioscience SAS today announced that the company has been awarded the French Tech Emergence Grant by BPI France in the context of the “Programme France 2030”. This grant funding allows TheraPPI to pursue its R&D activities to offer treatments for drug-resistant cancers and non-curable rare diseases.
…
Read more > LinkedIn post